Crossmark

Bioengineering strategies to optimize STING agonist therapy

Crossref DOI link: https://doi.org/10.1038/s44222-025-00337-y

Published Online: 2025-08-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dosta, Pere https://orcid.org/0000-0002-4407-1420
Cryer, Alexander M.

Prado, Michaela https://orcid.org/0000-0002-1024-7176
Artzi, Natalie
License Information

Text and Data Mining valid from 2025-08-04

Version of Record valid from 2025-08-04
More Information

Article History

Accepted: 17 June 2025

First Online: 4 August 2025

Competing interests

: The authors declare no competing interests.